ONO Pharma USA

ONO Pharma USA, INC., a subsidiary of Ono Pharmaceutical Co., Ltd., is a research and development-based pharmaceutical company. The company is developing a new drug, ONO-4685, which is an anti-PD-1/CD3 bispecific antibody that specifically binds to human PD-1 and CD3, and is being developed for the treatment of autoimmune diseases and hematologic malignancies.